FDA Inspection 1079620 — Almirall, LLC
The FDA completed an inspection of Almirall, LLC on December 19, 2018 in Exton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 19, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Exton, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)